HealthCare at HOME acquires Health Impetus
The acquisition marks HCAH’s entry into disease management services thereby becoming an integrated care management company
HealthCare at HOME (HCAH), a joint-venture between the Burman family (promoters of Dabur) and founders of Health Care At Home, UK, has completed the acquisition of Health Impetus, a disease management company involved in providing innovative solutions for the pharma companies to engage patients and doctors.
The acquisition marks HCAH’s entry into disease management services thereby becoming an integrated care management company, which is focused on making a real difference to patient care, outcomes and cost of treatment. HCAH will provide an array of services which will include disease awareness and diagnostics, patient support and awareness programmes, management of diseases through compliance programmes, drug delivery and administration, data analysis and outcome standardisation.
A range of patient care services, like EMI schemes for chronic ailments like cancer, diabetes, Hepatitis B etc, will be rolled out which will help patients to continue the treatment and meet the high cost of medications.
EH News Bureau
Comments are closed.